肿瘤周边神经元感觉反应衰减与癫痫易感性增强的分子变化
研究在小鼠枕叶皮层原位植入胶质瘤细胞后纵向监测视觉诱发电位,并于症状期激光显微切割取II-III层锥体神经元分析基因表达。与对照组相比,肿瘤周边神经元SNAP25与GABA-A受体α1亚基表达下降,谷氨酸能标志物无显著变化;给予苯二氮䓬反向激动剂DMCM进一步降低GABA-A信号后,两种荷瘤小鼠模型均出现癫痫发作。
要点
- 荷瘤小鼠视觉反应衰减可界定症状期,此时肿瘤周边II-III层锥体神经元SNAP25与GABA-A受体α1亚基表达下降。
- AMPA或NMDA受体亚基等谷氨酸能标志物未见显著变化。
- DMCM进一步降低GABA-A信号后,两种荷瘤小鼠模型均出现癫痫发作。
核心结论
- 研究揭示了肿瘤邻近区域主细胞发生的新的分子变化,这些改变可能成为改善患者生活质量的治疗靶点。
研究设计与样本
- 在小鼠枕叶皮层原位植入鼠胶质瘤细胞后纵向监测视觉诱发电位。
- 采用激光显微切割分析II-III层锥体神经元分子谱,并用局部场电位记录评估荷瘤动物相对对照小鼠的癫痫易感性。
主要发现
- 确定了荷瘤小鼠神经元功能障碍的时间进程,并基于视觉反应衰减界定症状期。
- 与对照组相比,肿瘤周边神经元SNARE复合体基因SNAP25与GABA-A受体α1亚基表达下降。
- 谷氨酸能标志物(即AMPA或NMDA受体亚基)未检测到显著变化。
- 给予苯二氮䓬反向激动剂DMCM进一步降低GABA-A信号后,两种荷瘤小鼠模型均出现癫痫发作。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma growth impacts on the structure and physiology of peritumoral neuronal networks, altering the activity of pyramidal neurons which drives further tumor progression. It is therefore of paramount importance to identify glioma-induced changes in pyramidal neurons, since they represent a key therapeutic target. METHODS: We longitudinal monitored visual evoked potentials after the orthotopic implant of murine glioma cells into the mouse occipital cortex. With laser microdissection, we analyzed layer II-III pyramidal neurons molecular profile and with local field potentials recordings we evaluated the propensity to seizures in glioma-bearing animals with respect to control mice. RESULTS: We determine the time course of neuronal dysfunction of glioma-bearing mice and we identify a symptomatic stage, based on the decay of visual response. At that time point, we microdissect layer II-III pyramidal neurons and evaluate the expression of a panel of genes involved in synaptic transmission and neuronal excitability. Compared to the control group, peritumoral neurons show a decrease in the expression of the SNARE complex gene SNAP25 and the alpha1 subunit of the GABA-A receptor. No significant changes are detected in glutamatergic (ie, AMPA or NMDA receptor subunit) markers. Further reduction of GABA-A signaling by delivery of a benzodiazepine inverse agonist, DMCM (methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate) precipitates seizures in 2 mouse models of tumor-bearing mice. CONCLUSIONS: These studies reveal novel molecular changes that occur in the principal cells of the tumor-adjacent zone. These modifications may be therapeutically targeted to ameliorate patients' quality of life.
引用
- Tantillo E, Scalera M, De Santis E, et al. Molecular changes underlying decay of sensory responses and enhanced seizure propensity in peritumoral neurons. Neuro Oncol. 2023. PMID: 36805257. doi:10.1093/neuonc/noad035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。